Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...

Delaware has seen a 65% increase in new biotechnology companies over the past decade, according to a recent report by the Delaware BioScience Association and the Delaware Prosperity Partnership. This ...

Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Over the past few decades, the Triangle’s life sciences ...

While the life sciences sector has made impressive advancements this year, particularly in artificial intelligence, the industry’s real estate market has continued to encounter hurdles. In such times, ...

Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...

After two years of layoffs and funding pullbacks, South San Francisco’s life science industry is showing stronger signs of a comeback— though more mega-rounds and less early-stage funding could ...

Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA. Cytisinicline's α4β2 partial agonism aims to reduce cravings and blunt ...